Skip to main content

Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study.

Publication ,  Journal Article
Spencer, FA; Allegrone, J; Goldberg, RJ; Gore, JM; Fox, KAA; Granger, CB; Mehta, RH; Brieger, D; GRACE Investigators,
Published in: Ann Intern Med
June 1, 2004

BACKGROUND: Statins administered early in patients with acute coronary syndromes may lead to modest reductions in recurrent ischemic events. OBJECTIVE: To examine the association between previous and early in-hospital statin therapy and the presentation and outcomes of an acute coronary syndrome. DESIGN: Cohort study. SETTING: 94 hospitals in 14 countries participating in the Global Registry of Acute Coronary Events (GRACE). PATIENTS: 19,537 patients with an acute coronary syndrome who were enrolled from April 1999 to September 2002. MEASUREMENTS: Statin use before and after presentation with an acute coronary syndrome and associated rates of myocardial infarction, hospital complications, and hospital mortality. The composite end point included death, in-hospital myocardial infarction, and stroke. RESULTS: Patients who were already taking statins when they presented to the hospital were less likely to have ST-segment elevation (odds ratio [OR], 0.79 [95% CI, 0.71 to 0.88]) or myocardial infarction (OR, 0.78 [CI, 0.70 to 0.86]). Patients who continued to take statins in the hospital were less likely to experience complications or die than patients who never received statins (OR, 0.66 [CI, 0.56 to 0.77]). Patients not previously taking statins who began statin therapy in the hospital were less likely to die than patients who never received statin therapy (OR, 0.38 [CI, 0.30 to 0.48]). However, adjustment for the hospital of admission attenuated the association between initiation of statin therapy and the composite end point (OR, 0.84 [CI, 0.65 to 1.10]). LIMITATIONS: This observational study cannot exclude confounding by clinical and hospital factors. CONCLUSIONS: These data support the hypothesis that statin therapy can modulate early pathophysiologic processes in patients with acute coronary syndromes. A randomized trial of statin therapy in acute myocardial infarction is warranted.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Ann Intern Med

DOI

EISSN

1539-3704

Publication Date

June 1, 2004

Volume

140

Issue

11

Start / End Page

857 / 866

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Syndrome
  • Stroke
  • Secondary Prevention
  • Myocardial Infarction
  • Middle Aged
  • Male
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Hospitalization
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Spencer, F. A., Allegrone, J., Goldberg, R. J., Gore, J. M., Fox, K. A. A., Granger, C. B., … GRACE Investigators, . (2004). Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study. Ann Intern Med, 140(11), 857–866. https://doi.org/10.7326/0003-4819-140-11-200406010-00006
Spencer, Frederick A., Jeanna Allegrone, Robert J. Goldberg, Joel M. Gore, Keith A. A. Fox, Christopher B. Granger, Rajendra H. Mehta, David Brieger, and David GRACE Investigators. “Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study.Ann Intern Med 140, no. 11 (June 1, 2004): 857–66. https://doi.org/10.7326/0003-4819-140-11-200406010-00006.
Spencer FA, Allegrone J, Goldberg RJ, Gore JM, Fox KAA, Granger CB, et al. Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study. Ann Intern Med. 2004 Jun 1;140(11):857–66.
Spencer, Frederick A., et al. “Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study.Ann Intern Med, vol. 140, no. 11, June 2004, pp. 857–66. Pubmed, doi:10.7326/0003-4819-140-11-200406010-00006.
Spencer FA, Allegrone J, Goldberg RJ, Gore JM, Fox KAA, Granger CB, Mehta RH, Brieger D, GRACE Investigators. Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study. Ann Intern Med. 2004 Jun 1;140(11):857–866.

Published In

Ann Intern Med

DOI

EISSN

1539-3704

Publication Date

June 1, 2004

Volume

140

Issue

11

Start / End Page

857 / 866

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Syndrome
  • Stroke
  • Secondary Prevention
  • Myocardial Infarction
  • Middle Aged
  • Male
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Hospitalization